Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models
Gedatolisib 在乳腺癌模型中表现出比单节点 PI3K/AKT/mTOR 抑制剂更优异的效力和疗效
期刊:NPJ Breast Cancer
影响因子:6.5
doi:10.1038/s41523-024-00648-0
Stefano Rossetti, Aaron Broege, Adrish Sen, Salmaan Khan, Ian MacNeil, Jhomary Molden, Ross Kopher, Stephen Schulz, Lance Laing
